It is well known that the licensing regime will set out the procedures for holding shareholders in listed companies and the obligation to disclose information. However, a number of shareholders in the company A have been questioned by the regulatory authorities, in disregard of the relevant provisions and in violation of the rules.

On 8 May, the Medical Research and Development Service Co. Ltd. (hereinafter referred to as the “intellectual Medicine”, 300149.SZ) issued a circular stating that the shareholders of the company had received deep-held regulatory correspondence for breaching the obligation to disclose information.

On the other hand, medicinal medicine has been less profitable for nearly two years, with a combined loss of more than 1 billion yuan renminbi in 2021 and 2022. The value of the ITS unit also dropped from the top 25 to less than 10 yuan. The ability to improve the performance and equity of medicinal medicine in 2023 has yet to be tested over time.

Untimely disclosure of shareholder irregularities

According to the bulletin, the combined share of the eight leading companies in the North Sea (hereinafter referred to as “the eight North Seas”) that were a former constitutional passion and its unanimous actioner decreased from 24.55 per cent to 16.25 per cent between 25 March 2016 and 27 September 2022, with a cumulative decline of 8.30 per cent.

It was further indicated that transactions had not been discontinued in accordance with the relevant provisions of the Securities Act when the cumulative change in the combined share of eight North Seas had reached 5 per cent. The Institute also concluded that eight copies of the Constitution and the North Sea failed to comply in a timely manner with the obligation to disclose information until 28 September 2022. It was further considered that the eight originals of the Constitution and the North Sea violated the relevant provisions, such as the rules on the listing of entrepreneurship panels.

It also calls for the use of medicinal medicine, past constitutional practices and eight bona fide letters in the North Sea to comply with the obligation to trade in listed company stocks and to comply with the obligation to disclose information in a timely manner; and to pay due attention to the above-mentioned issues, learn lessons and adapt them in a timely manner so as to prevent the recurrence of these problems.

At present, the issue referred to in the regulatory letter has not yet been answered and clarified by medicinal medicine.

A quarterly report shows that, as at the end of March 2023, eight North Seas had 13.69 per cent shares in medicinal medicine and had a constitutional share of 2.55 per cent in medicinal medicine. At the same time, the Constitution also held 70 per cent of the eight North Sea shares.

This is to say, the constitutional holding of 12.13 per cent of the share of medicinal medicine by direct plus indirect (eight in the North Sea) is higher than that of the second-largest shareholder of medicinal medicine (10.24 per cent) of the shareholders of the partnership in the management of the magnetic field (limited partnership) and is the actual controller of medicinal medicine.

It was also announced that in 2022 alone, the Constitutional Economy and eight North Seas had accumulated a reduction in the amount of 1970,055 million in medicinal medicinal medicinal medicine, which now stands at nearly 200 million yuan renminbi.

Two years of “incapacitated” loss of more than 1 billion

The actual control over the other face of a large-scale hand-held bag has been kept under pressure for two consecutive years.

Financial data show that in 2021, 2022, the principal income for medicinal medicine was 1.69 billion yuan renminbi and 1.27 billion yuan renminbi, with a net return of $402 million and $379 million yuan renminbi, with a net profit of $422 million and $607 million for the same period.

As can be seen, the combined loss of medicinal medicine for two years with a net profit of more than $1 billion. Between 2018 and 2020, there was an annual net profit of 0.83 to 150 million yuan for medicinal medicine.

Two years of “non-calculation” of medicinal medicine

Why have the profitability declined sharply? According to the annual report, the loss in performance in 2021 of medicinal medicine was due to a loss in commercial goodwill that occurred after the previous acquisition of the Shanghai Toxicology Chemical Research Ltd. (hereinafter referred to as “the top sea ideologies”) with $2,382 million. In 2021, a reduction in the amount of oxygen from the upper sea was prepared for 3.638 million.

In 2022, the net return of the mother tongue medicine was $379 million, a significant increase from the loss of $402 million in 2021, but the net profit of the medicinal medicine was still at a loss of $602 million after deduction of non-recurrent gains and losses.

According to the annual report, the non-recurrent gains and losses in thorium medicine for 2022 include, among other things, the proceeds of investments in the disposal of subsidiary high-量 (Hong-East) Bio Ltd. (hereinafter referred to as “the high-量”). This is just as much as $1,391 million. The medicinal medicine indicates that, after the introduction of a life-saving operation (i.e., the ion company’s high volume), the company will concentrate on the medicinal research and development and production services (CRO/CDMO) operation in Shanghai.

However, more operationally focused medicinal medicine was not available in 2023. A quarterly report shows that the principal income for the first three months of this year for medicinal medicine was $269 million, at a net loss of $2856.9 million for the mother and a net loss of income of $326.81 million, which was 30.45 per cent, 40.1.63 per cent and 49.91 per cent, respectively, over the same period last year.

Over 20 per cent of equity prices have fallen since this year

The public information shows that the front-loaded medicinal medicine was on the market in December 2010 at the deep entrepreneurship board. In 2018, the former constitutional passion and its co-components included occupants in high volume, including through cash plus stock exchange. In June 2018, CHF was renamed as a biomass and eventually renamed as a medicinal medicine in September 2020. The main company operations have also been transformed from the former yuan renminbi to the CRO/CDMO operation.

The annual report shows that the BSCRO share of total revenue generation in 2022, up to 54.91 per cent, the chemical CRO share 27.29 per cent, the large molecules CDMO share 6.23 per cent, and the low-pool sugar and semi-pooled sugar are less than 10 per cent.

The price of medicinal medicine has also experienced a wave of upwards after the company has changed.

Wind data show that, by 2020, medicinal medicine was standing at about 16 yuan renminbi. In May 2020, medicinal medicine was rebounded from around 10 yuan renminbi and by the end of September 2020 to a peak of 24.79 yuan renminbi/unit for nearly three years.

In June 2021, the artisan medicine came from around 20 yuan renminbi.

The Veterinary Society was informed that, as a result of the recent strategic cooperation agreement with the eastern drug industry (01875), the two sides will further consolidate and deepen their cooperation to expedite the development of radio-innovative drugs based on occasional technologies. The recent publication of the National Penitentiary International’s recommendations is a positive focus on the eastern drug industry.

The main international perspective is as follows:

Company CDMO further strengthens: corporate strategic cooperation with intellectual nuclear organisms for the overall development of enabling nuclear drugs. The Eastern Toxicology industry, with its extensive experience and technical advantages in the production of the ADC core particles and magnifications, together with its autonomous analytical capacity for key quality attributes, can provide a one-stop CDMO solution that is resistant to the production of the ADC original hydrate. Radiological Drug Identification, Research and Development, Production Technology Platform, with autonomous intellectual nuclear organisms, has covered more than 10 innovative nuclear diagnostic and treatment products. This cooperation will further consolidate the competitive advantages of the company in CDMO in the ADC area, as well as provide strong guarantees of entry into the RDC area, further enhancing the overall competitiveness of the company in the CDMO area.

CDMO has developed rapidly and has a clear competitive advantage: in 2022, the company’s CDMO operation earned $7.54 million, up from 35 per cent, in hand orders of $52 million, with a total of 45 projects, 18 projects in ADC, 23 projects in single resistance, drugs and four others, covering the different stages of clinical phase III. Orders are mainly from ADC and stand alone projects. The competitive advantage of the company’s CDMO operation is evident: (a) the company has the technical advantage of the core pupil and magnification process, as well as the autonomous analytical capacity of the key quality attributes of ADC, located in the national gradient in the area of ADC; (b) the production capacity, flexibilities and commercialization of the product; and (b) the company can provide customization services for client needs, covering the different sizes of small tests, medium tests and commercialization, and the company has now established single-resistant liquids and agents, the ADC original fluid, integrated production of dry and commercialization workshops, while meeting the high-standard quality management system, the GM capabilities and standards.

Corporate positioning is clear and development paths are clear: R&D pipelines continue to be advanced and the first piloted clinical trials of VEGF, in cooperation with the Synopsis, have been completed; TAC020 (innovative node) is being developed jointly with and is currently well under way. The marketable species, Parkingson, and the replacement of AUS$ 304 million in 2022, provide a better cash flow, and for the first time, the company has achieved a net operating cash flow of S$ 59.93 million. On this basis, the company continues to expand its advantages in the field of CDMO, which account for 77 per cent of the total, with 11 PhDs and 75 masters. Through the CDMO advantage of ADC, rapid growth is expected in the future. A detailed and complete version of the study, as well as a full version of the study by other companies and other industries, is available on the Veterinary Finance Web site and is available on the [Port American Unit study] - [Port Unit study] - [Port Unit study].

Veterinary finance seeks to invest in the American equity of every young incomprehensible in the world’s most well-established market, in the happiness and stimulus of the world’s leading shareholders. Every young person is given dignity and equal freedom of investment through the United States equity.

We are following with great vigour the emergence of capital markets such as United States units, port units, inventories, etc., and are providing professional financial information for investors and start-ups, market companies, financial institutions, port unit research analysis, financial circle socialization, brand marketing, meeting customization services, finance advisory services (FA), IPO counselling, overseas marketing, financial administration, port-owned investor relations, etc. We welcome the contacts of friends who need these services. Under the rubble, a geographically-based financial social platform for strangers is also operated: the world community of money.

Produced by: Guangming Popular Science Division

Planning: Zhan Zhao

Copywriter: Song Yajuan

Produced by: Wu Yuetong

Source: visual China

The development scale of the three major operators in Zhejiang is not small, especially Zhejiang Mobile. In recent years, the performance development of Zhejiang Unicom has made great progress, and the development pressure of Zhejiang Telecom is not small. This time, the operator caijing.com tried to introduce the background of the general managers of the local branches of operators in many second tier cities in the province, including Xu Guorong, general manager of Jiaxing Unicom, song Bo, general manager of Taizhou Telecom, and Wu Wentao, general manager of Jinhua Unicom, who have strong ability and great potential.

Xu Guorong, general manager of Jiaxing Unicom, has been in office for more than six years. He was general manager of Jinhua Unicom nine years ago

In recent years, the development of Zhejiang Unicom has shown a state of rapid development, while the local Jiaxing City has also developed rapidly in Zhejiang Province due to its economic growth and economic aggregate. Coupled with its high popularity, the development of Jiaxing Unicom is naturally deeply valued. The operation of shancaijing.com tries to sort out the development status of Jiaxing Unicom in Zhejiang Unicom and reveal the working background of Xu Guorong, general manager of the company.

The strength of Zhejiang Unicom is obvious to all, which is naturally inseparable from the performance contribution of many local and municipal branches. Jiaxing has been the latecomer in recent years. In 2019, it began to surpass Taizhou and is closer and closer to Shaoxing, becoming the fourth largest economy in Zhejiang Province.

With such a large economic volume, the development of Jiaxing Unicom will not be bad. When it comes to Jiaxing Unicom, it is natural to mention Xu Guorong, the general manager of the company. He has been deeply rooted in the local area for many years, witnessing and participating in the rise and development of the company.

According to the data, Xu Guorong served as the assistant general manager of Jiaxing Unicom as early as 2007, and then served as the deputy general manager of Jiaxing Unicom. During 2012, he was officially promoted to the head of local branches and general manager of Jinhua Unicom. During his tenure, he played a positive leadership role in Jinhua’s local 4G network construction.

Since then, after 2015, Xu Guorong has been transferred back to Jiaxing Unicom for six years.

During this period, he led Jiaxing Unicom to make outstanding achievements in digital reform, accelerated the application of 5g technology in industrial Internet, smart Park, smart fire protection and smart medical treatment, and actively promoted the integration of 5g into thousands of industries, which has become a model of digital reform in Jiaxing.

The general manager of Taizhou Telecom just adjusted this year, and song Bo, the former general manager of Zhejiang telecom marketing department, took over

In recent years, Zhejiang Telecom is constantly seeking a breakthrough, and its local branches are naturally constantly adjusting. According to the industrial and commercial registration information displayed by the enterprise investigation, the person in charge of Taizhou Telecom, a city with the highest economic development, was also replaced at the beginning of this year, and song Bo, the former general manager of Zhejiang telecom marketing department, was appointed. The operator caijing.com tried to sort out his working background.

According to the data, song Bo was the deputy general manager of the government enterprise customer department of Sichuan Telecom in his early years. Since then, he has been transferred to the general manager of Hangzhou telecom channel department at least in 2015. A few years later, he was promoted to the general manager of Zhejiang Telecom Marketing Department.

In the early stage of 5g development, as the general manager of the company’s marketing department, he attended the launching ceremony of 5g friendly customer experience activity held in Hangzhou and delivered a speech, introducing various applications of 5g in the industry and people’s life.

From his early work experience, it can be seen that he should be particularly good at the field of marketing. From government and enterprises to channels and then to the market, all provide strong support for his future management.

No wonder he was able to fully lead the company’s development after taking office as the general manager of Taizhou Telecom. He also said that Taizhou Telecom has always focused on industrial digitization and digital industrialization, enabled industrial transformation and upgrading, and made every effort to help Taizhou become a “wind vane” for the development of private economy in Zhejiang and even the whole country.

Taizhou is an important city with great development potential in Zhejiang Province. In the first half of this year, its total economic output was 272.3 billion yuan, continuing to maintain the sixth position in the province; In terms of population size, its permanent resident population is more than 6.6 million, ranking fourth in Zhejiang, second only to Hangzhou, Wenzhou and Ningbo, which also means that song Bo has a lot of development space in the future.

Wu Wentao, general manager of Jinhua Unicom, has been in office for two years. Previously, he served as general manager of the Sales Department of the provincial company

Jinhua is located in the middle of Zhejiang Province. It is an important transportation hub in the south of the Yangtze River. It is known as the heart of Zhejiang. The county-level city below Jinhua is famous for its small commodities in Yiwu, the ham in Dongyang and Hengdian film and television city. It is known as the capital of small commodities, the capital of ham and the capital of film and television. This time, the operator caijing.com tried to sort out the development status of Jinhua Unicom and introduce the background of current general manager Wu Wentao.

It is understood that Wu Wentao graduated from the computer major of Hangzhou University of Electronic Science and technology. In his early years, he should have been growing up in Zhejiang Unicom. He was transferred to the general manager of Jinhua Unicom in 2019. Before that, he was actually the general manager of the Sales Department of Zhejiang Unicom and began to serve as it in 2016 at least. It can be seen that he has rich market experience.

In recent years, the performance of Zhejiang Unicom has developed rapidly, among which the market business is one of the main sources of performance growth, among which Wu Wentao has also contributed a lot. It can be seen that the general manager of Jinhua Branch of China Unicom in Zhejiang attaches great importance to the development of China Unicom.

The economic development of Jinhua has ranked among the top seven in Zhejiang Province in recent years, with a total population of about 5.56 million. Now Jinhua and Yiwu form the Jinyi metropolitan area. In the future, it will strengthen economic ties with Quzhou, Lishui and other places, and will also radiate and drive the development of Jiangxi and other central regions. Therefore, Jinhua Unicom has great development potential in the future.

After taking office, Wu Wentao combined with the company’s network and technical advantages and signed strategic cooperation agreements with many local school enterprises, government and enterprise customers, which also further promoted the development of the company’s performance.

Jackson Yee

Sina entertainment news February 22nd, “this is hip-hop” media meet will be held in Shanghai, Yiyang Qianxi, Show Luo, Han Geng, Huang Zitao four star captain appeared. The relationship between the four male artists became very good because they recorded the same program for a long time. Huang Zitao revealed that he often said Yiyang Qianxi “I love you”, but thousand seals revealed that Huang Zitao had sent his dress to, and asked, “is it not cute?”

At the “hip hop” meeting on the same day, the four star captains who have become very close staged many scenes of “falling in love and killing each other”. Among them, Huang Zitao and Yiyang Qianxi are very interesting to the interaction between the brothers. In an interview with the host, Huang Zitao revealed that he usually said “I love you” to Qianxi in private, but Qianxi rarely replied to anything. He often called Qianxi with several long wechat messages, and Qianxi only replied with “Oh” and “ah”. Between the “complaints”, Zitao showed a funny expression of “very hurt”.

Other media are concerned about Huang Zitao’s emotional situation. Speaking frankly, Zi Tao, who has been empty for two or three years, admitted that he would talk about making girlfriends when sending messages to Han Geng and Qian Xi, “ask them ‘what do you think of this’, but in fact, he can’t get any results. Without that kind of fate, he can’t meet any good girls.” When asked by the media about Qian Xi’s “how does Zitao talk to you”, Qian Xi did not give his brother “mercy” and broke the news: “he sent his yellow peach (Huang Zitao’s female dress) avatar and asked me, ‘is this cute? I pushed her wechat to you?’ that’s all.” Zi Tao, who was exposed by his brother as “narcissistic”, had no choice but to force his respect and said, “I really have no way. I don’t have a girl. I can only send myself!” (xlzy / text)